“Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting: 52-Week Data From the Phase 4 ARTISTYK Study”. 2025. SKIN The Journal of Cutaneous Medicine 9 (6): s649. https://doi.org/10.25251/7j9e8h28.